New research has found that stressful or unsafe environments, negative expectations and a lack of social support during and after the psychedelic experience were all associated with negative outcomes when taking psychedelics.
Read morePsychedelics and Chronic Pain
This research article looks at some preliminary clinical findings that suggest potential efficacy of psychedelics for chronic pain, and the need for further research.
Read more10 Podcasts on Psychedelics
Top 10 Books on Psychedelics
Preparing the Body for a Psychedelic Experience
Here are some tips on how to prepare for a psychedelic experience to reduce side effects and optimize beneficial effects on your body and mind.
Read moreIntegration
The ups and downs of psychedelic integration can be a lot to navigate! Learn 5 tips to make this journey successful.
Read moreIntentions
Setting a clear psychedelic intention can help shape your experience.
We can maximize insights and transformations with effective intention-setting.
Read morePreparing for a Psychedelic Experience
Here are some tips on preparing for your experience.
Read moreNext-Gen Psilocybin
CYB003 is a next-generation psilocybin designed to provide a faster onset of action and to reduce the duration of effects, ultimately thinning the financial barrier to access of this medicine in a medical setting.
The trial’s interim data demonstrated “rapid, robust, and clinically significant reduction of depression symptoms” three weeks after a single 12mg dose of CYB003.
Read morePsychedelics and Psychosis
In the 1960s, psychedelic research was driven underground. Now it’s re-emerging – with lessons for the study of psychosis.
Read moreHistory of Ibogaine
Author Julien Bonhomme, Ph.D explores how Euro-American psychedelic communities have appropriated Bwiti ibogaine rituals, creating a liminal experience that incorporates from both traditions.
Click here for the full article.
Read more